Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Adobe beats Q3 expectations but shares fall 10% due to disappointing Q4 guidance, impacting investor sentiment.
UnityPoint Health-Grinnell introduces Neoprobe Gamma Detection for precise breast cancer surgery, enhancing patient care and personalized treatment.
iShares U.S. Technology ETF saw diverse changes in the 3rd quarter, with valuations reaching $90.72M and $2.45M amid varying percentage ...
A recent clinical trial in Japan reveals that virtual reality therapy can greatly improve the physical and emotional symptoms of ...
Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Discover the game-changing role of Artificial Intelligence (AI) in the field of Radiology, enhancing patient care at Regional Medical Imaging ...
© 2024 FinOracle.net - Your financial oracle, analytics and forecasts for stocks, cryptocurrency.